Stock·NASDAQ·Technology
Amkor Technology Inc. (AMKR)
- Market cap
- $10.92B
- P/E
- 20.98
- Dividend yield
- 0.76%
- Street target
- $73.50median of 11 analysts
- 52-week range
- $29.50 $96.68
The short version
Where AMKR stands today, in four lines, and what CleaRank Financial AI makes of it.
AMKR at a glance
Amkor Technology Inc. (AMKR): Sell, 21/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($51.16 and $57.69).
- Earnings AMKR beat estimates in 5 of its last 6 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $1.0B and bought $48.2M over the last 18 months.
- Valuation P/E of 21.0 against 35.1 for the Technology sector: a discount to peers (-40%).
Figures as of October 16, 2026.
CleaRank Financial AI
Amkor Technology Inc. (AMKR) is currently trading at $44.05, below its 50-day SMA of $51.16 and 200-day SMA of $57.69, signaling a bearish trend.
The company's recent earnings have shown positive surprises, with EPS beating estimates by 45.83% in the latest reported quarter, yet the stock price reacted negatively with a -24.74% drop. This divergence suggests that positive earnings are not currently translating into investor confidence, potentially due to broader market concerns or specific company headwinds. While Wall Street analysts maintain a 'Buy' consensus with a median price target of $73.50, implying significant upside, the current technical and insider sentiment presents a considerable risk to that outlook.
Only on CleaRank
Figures we compute ourselves from AMKR's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $44.05 is 13.9% below the 50-day simple moving average of $51.16.Price above its 200-day average ›
The price is 23.6% below the 200-day simple moving average of $57.69.50-day average above the 200-day ›
The 50-day average ($51.16) is 11.3% below the 200-day average ($57.69), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 22% of its 52-week range, between $29.50 and $96.68.
AMKR share price
Pick a period: each tab shows how far AMKR has moved over it, to the last close.
Today's trading
Where AMKR sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 20.98 is 40.2% below the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 1.47 is 80.7% below the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $555.5M on revenue of $7.5B, a net margin of 7.4%.Beat estimates in most recent reports ›
AMKR beat the EPS estimate in 5 of its last 6 reports.Pays a dividend ›
The trailing dividend yield is 0.76%, or $0.3341 a share a year.
Key statistics
The headline figures for AMKR.
As of October 16, 2026, AMKR trades at $44.05, with a market value of $10.92B, a P/E ratio of 20.98 and a dividend yield of 0.76%.
What the numbers say
CleaRank Financial AI's reading of AMKR's valuation, growth and risks.
Amkor Technology Inc. (AMKR) exhibits a P/E ratio of 20.98, which is below the sector median of 35.1, suggesting a potentially attractive valuation relative to peers.
The company's price-to-sales ratio stands at 1.47, also below the sector median of 7.6. The debt-to-equity ratio is 0.57, which aligns with the sector average. Despite the seemingly favorable valuation metrics compared to the sector, the company's fundamentals are overshadowed by significant insider selling. The substantial net seller position among insiders, with over $1 billion in sales, raises concerns about the underlying health and future prospects of the company, even as revenue growth was reported at a strong 25.6%.
AMKR against the Technology sector
How AMKR compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: AMKR trades at a notable discount to sector peers (-40%), which may indicate undervaluation or specific company headwinds.
Return vs XLK: Since May 5, 2025, AMKR has gained 147.9% against a gain of 74.3% for XLK.
Performance against XLK
AMKR and the Technology sector fund over the same days.
Revenue and earnings
How much AMKR sells, and how much of it becomes profit.
Revenue growth: Revenue grew 6.2% in FY2025 to $6.7B, from $6.3B a year earlier.
Profit margin: The net margin was 5.6% in FY2025, down from 5.6% the year before.
Profitable: AMKR earned $376M in FY2025.
Earnings reality check
Did AMKR beat what analysts expected, and how did the stock react?
Earnings record: AMKR beat the analyst estimate in 5 of the last 6 quarters.
Market reaction: The stock fell in the first session after 3 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 27, 2026after close | $0.48 | $0.70 | +45.83% | -24.74% | -16.26% |
| Feb 9, 2026after close | $0.44 | $0.69 | +56.82% | +1.79% | -10.81% |
| Oct 27, 2025after close | $0.43 | $0.51 | +18.60% | -3.07% | +14.04% |
| Jul 28, 2025after close | $0.16 | $0.22 | +37.50% | +18.13% | +5.28% |
| Apr 28, 2025after close | $0.09 | $0.09 | +0.00% | -2.63% | +1.66% |
| Feb 10, 2025after close | $0.38 | $0.43 | +13.16% | -11.33% | -6.03% |
As of October 16, 2026, AMKR has beaten the analyst EPS estimate in 5 of its last 6 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on July 27, 2026, came in 45.83% above the estimate and the stock moved -24.74% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 33.4, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 33.4 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of AMKR
The score, the reasoning behind it, and what could move the price next.
Amkor Technology Inc. (AMKR) is trading below its 50-day SMA of $51.16 and its 200-day SMA of $57.69, indicating a bearish trend.
The 14-day RSI is at 33.38, classified as bearish momentum, suggesting a lack of buying interest and potential for further price depreciation. The MACD is also negative at -1.40, reinforcing the bearish sentiment. The current price of $44.05 is significantly below the moving averages. Volume was notably higher than average on recent trading days, suggesting increased activity but not necessarily positive conviction. The technical setup, characterized by lower highs and lower lows implied by the price action relative to SMAs, points towards continued downward pressure.
Positive Earnings Surprises ›
Amkor Technology Inc. has consistently beaten EPS estimates, most recently by 45.83%, indicating operational strength.
Source: Earnings ReportsWall Street 'Buy' Consensus and Price Target ›
11 Wall Street analysts maintain a 'Buy' rating with a median price target of $73.50, suggesting significant upside potential if sentiment shifts.
Source: Wall Street Analysts
Bearish Technical Setup ›
AMKR is trading below its 50-day SMA ($51.16) and 200-day SMA ($57.69), with a bearish RSI of 33.38, suggesting continued downward price momentum.
Source: Technical Analysis Data
- The stock is trading below its 50-day and 200-day moving averages ($51.16 and $57.69), indicating a bearish trend. Consider waiting for a confirmed break above these levels before considering a long position.
Technical indicators
Momentum and trend for AMKR, from its daily closes.
As of October 16, 2026, with AMKR at $44.05, its 14-day RSI is 33.4 (showing bearish momentum without being oversold), its 50-day simple moving average is $51.16 and its 200-day is $57.69.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What AMKR moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, AMKR's 1-year correlation of daily returns is +0.57 with S&P 500 (SPY), +0.65 with Nasdaq 100 (QQQ), +0.21 with Bitcoin (BTC) and +0.16 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
7 of 11 analysts rate it a buy or strong buy, 4 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $73.50 is 66.9% above the price.More buy ratings than three months ago ›
7 of 11 rate it a buy now, against 5 of 10 three months ago.
AMKR Wall Street View
12-month price targets
The price, $44.05, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Aug 27, 2026 | B of A Securities | Initiates | Buy |
| Jul 28, 2026 | Morgan Stanley | Maintains | Equal-Weight |
| Jul 28, 2026 | B. Riley Securities | Maintains | Neutral |
| Jul 28, 2026 | Needham | Reiterates | Buy |
| Jul 25, 2026 | UBS | Upgrade | Buy |
| Jul 24, 2026 | UBS | Upgrade | Buy |
As of October 16, 2026, 11 Wall Street analysts cover AMKR: 7 rate it a buy or strong buy, 4 a hold and 0 a sell or strong sell. Their 12-month price targets range from $65.00 to $92.00, with a median of $73.50, 66.9% above the price of $44.05.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
AMKR trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
AMKR moves about 3.6% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much AMKR tends to move, against the market and on its own.
The long record
AMKR's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 3.56% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 63.7%, from July 2024 to April 2025, regained by December 2025.Most 1-year holds ended higher ›
64% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $50,896, against $42,525 in the S&P 500 (SPY).
AMKR Drawdowns & Recovery
As of October 16, 2026, AMKR's worst peak-to-trough fall over the last 10 years with dividends reinvested was -63.7% (July 2024 to April 2025); it regained that peak by December 2025, 8 months after the low, and 64% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into AMKR in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: AMKR beat the S&P 500 over this period: $50,896 against $42,525.
A $10,000 investment in AMKR in October 2016 would be worth about $50,896 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to AMKR, and which have not.
Strongest month, November: an average of +13.49%, up in 8 of 10 years.
Weakest month, August: an average of -4.29%, up in 4 of 10 years.
This month, October: has averaged +4.12%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, AMKR's strongest calendar month has been November (average +13.49%, up in 8 of 10 years) and its weakest August (average -4.29%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in AMKR, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in AMKR today could grow to about $25,108 by 2036 in the base case, with a 90th-percentile outcome near $190,488 and a 10th-percentile outcome around $3,310. The simulation models price only; at today's 0.76% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
AMKR Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $63.66 for AMKR by 2030 in the base case, from $44.05 today (1.4x over 4 years). The 10th-percentile path ends near $17.67. These are outcomes of a Monte Carlo simulation run on AMKR's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $25.45 | $48.30 | $91.67 | |
| 2028 | $21.40 | $52.96 | $131 | |
| 2029 | $19.14 | $58.06 | $176 | |
| 2030 | $17.67 | $63.66 | $229 | |
| 2031 | $16.66 | $69.80 | $293 |
Method: a lognormal simulation of AMKR's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. AMKR is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation.
Insider trading
What the people running the company have bought and sold.
AMKR insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $48.2M on the open market and sold $1.0B.
As of October 16, 2026, AMKR insiders reported 45 open-market sales worth $1.0B and 5 open-market purchases worth $48.2M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Douglas A Alexander
Director
|
Sell | 5.0K | $275.0K |
| Oct 2, 2026 | Douglas A Alexander
Director
|
Option | 5.0K | $42.6K |
| Sep 8, 2026 | Megan Faust
Chief Financial Officer
|
Sell | 1.0K | $49.1K |
| Aug 17, 2026 | Mark N. Rogers
General Counsel
|
Sell | 5.0K | $298.9K |
| Aug 17, 2026 | Mark N. Rogers
General Counsel
|
Option | 5.0K | $37.0K |
| Aug 11, 2026 | Megan Faust
Chief Financial Officer
|
Sell | 1.0K | $54.5K |
| Aug 7, 2026 | Douglas A Alexander
Director
|
Sell | 5.0K | $279.1K |
| Aug 7, 2026 | Douglas A Alexander
Director
|
Option | 5.0K | $42.6K |
| Aug 6, 2026 | Guillaume Marie Jean Rutten
Director
|
Sell | 50.0K | $2.7M |
| Jul 30, 2026 | Kevin K Engel
Officer and Director
|
Sell | 3.2K | $151.4K |
| Jul 30, 2026 | Winston J. Churchill Jr.
Director
|
Grant | 100 | - |
| Jul 20, 2026 | Agnes C Kim
Beneficial Owner of more than 10% of a Class of Security
|
Option | 450.0K | $4.3M |
| Jul 20, 2026 | James Jungsup Kim
Beneficial Owner of more than 10% of a Class of Security
|
Option | 450.0K | $4.3M |
| Jul 16, 2026 | Mark N. Rogers
General Counsel
|
Sell | 5.0K | $325.6K |
| Jul 16, 2026 | Mark N. Rogers
General Counsel
|
Option | 5.0K | $37.0K |
| Jul 14, 2026 | Megan Faust
Chief Financial Officer
|
Sell | 1.0K | $69.9K |
| Jun 30, 2026 | Kevin K Engel
Chief Executive Officer
|
Grant | 8.7K | - |
| Jun 30, 2026 | Megan Faust
Chief Financial Officer
|
Grant | 8.7K | - |
| Jun 30, 2026 | Guillaume Marie Jean Rutten
Director
|
Grant | 8.7K | - |
| Jun 16, 2026 | Mark N. Rogers
General Counsel
|
Sell | 5.0K | $431.1K |
| Jun 16, 2026 | Mark N. Rogers
General Counsel
|
Option | 5.0K | $37.0K |
| Jun 12, 2026 | Winston J. Churchill Jr.
Director
|
Sell | 5.0K | $391.0K |
| Jun 12, 2026 | Winston J. Churchill Jr.
Director
|
Option | 5.0K | $97.0K |
| Jun 12, 2026 | Susan Y Kim
Director and Beneficial Owner of more than 10% of a Class of Security
|
Grant | 9.9K | - |
| Jun 9, 2026 | Megan Faust
Chief Financial Officer
|
Sell | 1.0K | $70.3K |
| May 19, 2026 | Megan Faust
Chief Financial Officer
|
Sell | 1.0K | $64.6K |
| May 18, 2026 | Mark N. Rogers
General Counsel
|
Sell | 5.0K | $358.2K |
| May 18, 2026 | Mark N. Rogers
General Counsel
|
Option | 5.0K | $37.0K |
| May 13, 2026 | Winston J. Churchill Jr.
Director
|
Grant | 9.9K | - |
| May 13, 2026 | Susan Y Kim
Director and Beneficial Owner of more than 10% of a Class of Security
|
Option | 9.9K | $738.1K |
| May 13, 2026 | Maryfrances Mccourt
Director
|
Grant | 9.9K | - |
| May 13, 2026 | Guillaume Marie Jean Rutten
Director
|
Grant | 482 | - |
| May 13, 2026 | Gil Coleman Tily
Director
|
Grant | 9.9K | - |
| May 13, 2026 | David N. Watson
Director
|
Grant | 9.9K | - |
| May 11, 2026 | Gil Coleman Tily
Director
|
Sell | 15.0K | $1.2M |
| May 8, 2026 | Guillaume Marie Jean Rutten
Director
|
Sell | 50.0K | $3.7M |
| May 5, 2026 | Roger Anthony Carolin
Director
|
Sell | 20.0K | $1.5M |
| May 5, 2026 | Winston J. Churchill Jr.
Director
|
Sell | 7.0K | $535.2K |
| May 5, 2026 | Douglas A Alexander
Director
|
Sell | 5.0K | $382.9K |
| May 5, 2026 | Douglas A Alexander
Director
|
Option | 5.0K | $46.9K |
| May 5, 2026 | Roger Anthony Carolin
Director
|
Option | 20.0K | $234.2K |
| Apr 16, 2026 | Mark N. Rogers
General Counsel
|
Sell | 5.0K | $297.2K |
| Apr 16, 2026 | Mark N. Rogers
General Counsel
|
Option | 5.0K | $37.0K |
| Apr 7, 2026 | Susan Y Kim
Director and Beneficial Owner of more than 10% of a Class of Security
|
Option | 20.0K | $113.2K |
| Apr 7, 2026 | Robert Randolph Morse
Director
|
Option | 20.0K | $113.2K |
| Mar 31, 2026 | Kevin K Engel
Chief Executive Officer
|
Grant | 8.7K | - |
| Mar 31, 2026 | Megan Faust
Chief Financial Officer
|
Grant | 8.7K | - |
| Mar 31, 2026 | Guillaume Marie Jean Rutten
Director
|
Grant | 8.7K | - |
| Mar 16, 2026 | Mark N. Rogers
General Counsel
|
Sell | 5.0K | $222.7K |
| Mar 16, 2026 | Mark N. Rogers
General Counsel
|
Option | 5.0K | $37.0K |
| Feb 25, 2026 | Farshad Haghighi
Officer
|
Sell | 15.6K | $789.0K |
| Feb 25, 2026 | David N. Watson
Director
|
Option | 20.0K | $113.2K |
| Feb 24, 2026 | Guillaume Marie Jean Rutten
Director
|
Sell | 20.0K | $976.0K |
| Feb 24, 2026 | Kevin K Engel
Chief Executive Officer
|
Sell | 12.5K | $609.4K |
| Feb 24, 2026 | Kevin K Engel
Chief Executive Officer
|
Grant | 910 | - |
| Feb 24, 2026 | Megan Faust
Chief Financial Officer
|
Grant | 3.5K | - |
| Feb 24, 2026 | Farshad Haghighi
Officer
|
Grant | 1.8K | - |
| Feb 24, 2026 | Mark N. Rogers
General Counsel
|
Grant | 1.9K | - |
| Feb 24, 2026 | Guillaume Marie Jean Rutten
Director
|
Grant | 10.7K | - |
| Feb 20, 2026 | Kevin K Engel
Chief Executive Officer
|
Grant | 16.9K | - |
| Feb 20, 2026 | Megan Faust
Chief Financial Officer
|
Grant | 34.9K | - |
| Feb 20, 2026 | Farshad Haghighi
Officer
|
Grant | 17.6K | - |
| Feb 20, 2026 | Mark N. Rogers
General Counsel
|
Grant | 16.1K | - |
| Feb 20, 2026 | Guillaume Marie Jean Rutten
Director
|
Grant | 172.3K | - |
| Feb 18, 2026 | Kevin K Engel
Chief Executive Officer
|
Grant | 7.4K | - |
| Feb 18, 2026 | Megan Faust
Chief Financial Officer
|
Grant | 13.9K | - |
| Feb 18, 2026 | Farshad Haghighi
Officer
|
Grant | 7.6K | - |
| Feb 18, 2026 | Mark N. Rogers
General Counsel
|
Grant | 6.5K | - |
| Feb 18, 2026 | Guillaume Marie Jean Rutten
Director
|
Grant | 41.5K | - |
| Feb 17, 2026 | Guillaume Marie Jean Rutten
Director
|
Sell | 10.0K | $458.9K |
| Feb 17, 2026 | Kevin K Engel
Chief Executive Officer
|
Sell | 5.3K | $244.7K |
| Feb 17, 2026 | Mark N. Rogers
General Counsel
|
Sell | 5.0K | $234.6K |
| Feb 17, 2026 | Mark N. Rogers
General Counsel
|
Option | 6.9K | $37.0K |
| Feb 13, 2026 | Kevin K Engel
Chief Executive Officer
|
Grant | 1.3K | - |
| Feb 13, 2026 | Megan Faust
Chief Financial Officer
|
Grant | 4.2K | - |
| Feb 13, 2026 | Farshad Haghighi
Officer
|
Grant | 1.8K | - |
| Feb 13, 2026 | Guillaume Marie Jean Rutten
Director
|
Grant | 13.9K | - |
| Feb 12, 2026 | 915 Investments, L. P.
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 10.0M | $484.9M |
| Feb 12, 2026 | John T Kim
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 10.0M | $484.9M |
| Jan 16, 2026 | Mark N. Rogers
General Counsel
|
Sell | 5.0K | $246.4K |
| Jan 16, 2026 | Mark N. Rogers
General Counsel
|
Option | 5.0K | $37.0K |
| Jan 15, 2026 | Guillaume Marie Jean Rutten
Director
|
Sell | 10.0K | $531.4K |
| Dec 31, 2025 | Kevin K Engel
Officer
|
Grant | 8.7K | - |
| Dec 31, 2025 | Megan Faust
Chief Financial Officer
|
Grant | 8.7K | - |
| Dec 31, 2025 | Guillaume Marie Jean Rutten
Chief Executive Officer
|
Grant | 8.7K | - |
| Dec 26, 2025 | 2023 Grantor Retained Annuity Trust Of Susan Y. Kim
Trustee
|
Grant | 725.0K | - |
| Dec 26, 2025 | Susan Y Kim
Director and Beneficial Owner of more than 10% of a Class of Security
|
Grant | 725.0K | - |
| Dec 19, 2025 | Agnes C Kim
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 5.8M | - |
| Dec 19, 2025 | James Jungsup Kim
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 5.8M | - |
| Dec 16, 2025 | Mark N. Rogers
General Counsel
|
Sell | 20.0K | $859.0K |
| Dec 16, 2025 | Mark N. Rogers
General Counsel
|
Option | 20.0K | $148.0K |
| Dec 15, 2025 | Guillaume Marie Jean Rutten
Chief Executive Officer
|
Sell | 10.0K | $448.0K |
| Dec 15, 2025 | Winston J. Churchill Jr.
Director
|
Sell | 5.0K | $221.5K |
| Dec 15, 2025 | Winston J. Churchill Jr.
Director
|
Option | 5.0K | $97.0K |
| Dec 12, 2025 | Gil Coleman Tily
Director
|
Sell | 20.0K | $928.8K |
| Dec 12, 2025 | Maryfrances Mccourt
Director
|
Sell | 20.0K | $920.4K |
| Dec 12, 2025 | Kevin K Engel
Officer
|
Sell | 11.0K | $508.3K |
| Dec 12, 2025 | Maryfrances Mccourt
Director
|
Option | 20.0K | $387.8K |
| Dec 4, 2025 | 2023 Grantor Retained Annuity Trust Of Susan Y. Kim
Trustee
|
Grant | 758.0K | - |
| Dec 4, 2025 | Susan Y Kim
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 758.0K | - |
| Nov 20, 2025 | 2024 Grantor Retained Annuity Trust Of Agnes C. Kim
Trustee
|
Grant | 705.0K | - |
| Nov 20, 2025 | 2024 Grantor Retained Annuity Trust Of James J. Kim
Trustee
|
Grant | 965.0K | - |
| Nov 20, 2025 | 2024 Grantor Retained Annuity Trust Of Susan Y. Kim
Trustee
|
Grant | 876.0K | - |
| Nov 20, 2025 | Susan Y Kim
Director and Beneficial Owner of more than 10% of a Class of Security
|
Grant | 965.0K | - |
| Nov 20, 2025 | Susan Y Kim
Director and Beneficial Owner of more than 10% of a Class of Security
|
Grant | 2.5M | - |
| Nov 17, 2025 | Mark N. Rogers
General Counsel
|
Sell | 20.0K | $633.8K |
| Nov 17, 2025 | Guillaume Marie Jean Rutten
Chief Executive Officer
|
Sell | 10.0K | $316.8K |
| Nov 17, 2025 | Mark N. Rogers
General Counsel
|
Option | 20.0K | $148.0K |
| Nov 14, 2025 | Kevin B Engel
Officer
|
Grant | 669 | - |
| Nov 14, 2025 | Farshad Haghighi
Officer
|
Grant | 797 | - |
| Nov 4, 2025 | T. Kim 2024 Grat #1 John
Trustee
|
Grant | 806.0K | - |
| Nov 4, 2025 | T. Kim 2024 Grat #2 John
Trustee
|
Grant | 40.8K | - |
| Nov 4, 2025 | John T Kim
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 846.8K | - |
| Oct 15, 2025 | Guillaume Marie Jean Rutten
Chief Executive Officer
|
Sell | 10.0K | $307.4K |
| Sep 30, 2025 | Kevin B Engel
Officer
|
Grant | 8.7K | - |
| Sep 30, 2025 | Megan Faust
Chief Financial Officer
|
Grant | 8.7K | - |
| Sep 30, 2025 | Guillaume Marie Jean Rutten
Chief Executive Officer
|
Grant | 8.7K | - |
| Sep 23, 2025 | Guillaume Marie Jean Rutten
Chief Executive Officer
|
Sell | 10.0K | $300.0K |
| Sep 9, 2025 | Farshad Haghighi
Officer
|
Sell | 11.8K | $294.8K |
| Aug 1, 2025 | Agnes C Kim
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 441.6K | $9.6M |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.